Adenoviruses (AdVs) have recently become widely used
therapeutic
vectors for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
vaccine. AdVs are large, nonenveloped viruses with an icosahedral
capsid formed from several proteins that encloses double-stranded
DNA. These proteins are the main components and key players in initial
stages of infection by the virus particles, so their heterogeneity
and content must be evaluated to ensure product and process consistency.
Peptide mapping can provide detailed information on these proteins,
e.g., their amino acid sequences and post-translational modifications
(PTMs), which is crucial for the development and optimization of the
manufacturing processes. However, sample preparation remains the main
bottleneck for successful proteomic analysis of the viral proteins
(VPs) of AdVs due to their low concentrations and vast stoichiometric
ranges. To address this problem, we have developed a fast and efficient
protocol for preparing samples for proteomic analysis of VPs of AdV5
that requires no cleaning step prior to liquid chromatography–tandem
mass spectrometry (LC-MS/MS). The approach enabled identification
of 92% of amino acids in AdV5 VPs on average and quantification of
53 PTMs in a single LC-MS/MS experiment using trypsin protease. The
data obtained demonstrate the method’s potential utility for
supporting the development of novel AdV-based gene therapy products
(GTPs).